Hyperplasia of the Gums Following Dilantin Therapy, with Gingivectomy for Correction

Thompson, Edward; Gillespie, James B.

doi:10.14219/jada.archive.1941.0250

Cited by 4 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The surgical treatment of choice is the gingivectomy, which was first advocated for drug-induced gingival overgrowth in 1941 (Thompson & Gillespie 1941). The soft tissue wall of the pocket is excised (Wang & Greenwell 2001).…”

Section: Scalpel Gingivectomymentioning

confidence: 99%

The management of drug‐induced gingival overgrowth

Mavrogiannis

Ellis

Thomason

et al. 2006

J Clinic Periodontology

118

View full text Add to dashboard Cite

DIGO is a common clinical problem that often requires intervention. Non-surgical techniques can limit the occurrence of this unwanted affect, reduce the extent of plaque-induced gingival inflammation and reduce the rate of recurrence. Wherever possible this management strategy should be adopted first. Surgical treatment is often the most reliable option and scalpel gingivectomy remains the treatment of choice. Further investigations are required to develop appropriate management strategies to prevent recurrence of DIGO.

show abstract

Section: Scalpel Gingivectomymentioning

confidence: 99%

The management of drug‐induced gingival overgrowth

Mavrogiannis

Ellis

Thomason

et al. 2006

J Clinic Periodontology

118

View full text Add to dashboard Cite

show abstract

“…Despite all these nonsurgical treatment attempts, surgical management remains the most common approach for overgrown gingiva or mucosa, encompassing techniques such as gingivectomy, flap surgery, electrosurgery, and laser excision [ 27 ]. Gingivectomy was first introduced to the management of drug-influenced gingival overgrowth by Thompson and Gillespie in 1941 [ 31 ]. On the other hand, flap surgery may be advocated for patients of mild-to-moderate overgrowth accompanied by both bone and attachment loss.…”

Section: Discussionmentioning

confidence: 99%

Nifedipine-Influenced Enlargement of the Masticatory Mucosa in an Elderly Edentulous Patient: A Rare Case Report with a Two-Year Follow-Up

Sun,

Pan,

Zhang

et al. 2024

Case Reports in Dentistry

View full text Add to dashboard Cite

Drug-influenced gingival enlargement is a common side effect associated with certain medications, particularly calcium channel blockers like nifedipine, which has been extensively documented. However, the occurrence of nifedipine-influenced masticatory mucosa overgrowth in edentulous patients is rare. Here, we present a case of nifedipine-influenced mucosal enlargement persisting in a 67-year-old edentulous patient 3 months after the extraction of all his teeth. The patient underwent flap surgery and alveoloplasty to excise the overgrown tissue, followed by complete denture restoration. The antihypertensive medication was replaced with valsartan. A 2-year follow-up revealed no recurrence of overgrowth, indicating the effectiveness of this management strategy for such clinical situation.

show abstract

“…It is frequently necessary to consider surgical re‐contouring of the gingival tissue to facilitate oral hygiene, as well as to overcome problems with aesthetics, speech or masticatory function in patients with drug‐induced gingival overgrowth. The surgical treatment of choice is gingivectomy, which was first advocated for drug‐induced gingival overgrowth in 1941 (Thompson & Gillespie 1941). Conventionally, the excess tissue is released by means of a long bevel incision, which should ideally allow the complete removal of pocket tissue as part of the excised tissue mass, particularly in the inter‐dental region.…”

Section: Methodsmentioning

confidence: 99%